INTRODUCTION
Gestational diabetes (GDM) is defined as glucose intolerance of variable severity with onset or first recognition during the present pregnancy and reverting to normal after the puerperium. 1 The frequency of gestational diabetes mellitus is 0.6% -15% of pregnant woman. 2 Whereas the study performed in Singapore showed the incidence ranges from 1.1% to 13.3% of the population. As the modern trend is towards the delay starting family which is the main factor responsible for increase prevalence of GDM. Since, this condition is associated with the adverse effect on mother and fetus, so it is important to find out the GDM by screening of all the pregnant women. 3 The adverse effect associated with GDM is ketoacidosis, vasculopathy, infection of genital criteria. [5] [6] [7] Most obstetricians are still reluctant to perform screening among the pregnant women with no risk factors because they are not convincing of the results. The main aim of our study is to observe the feasibility of using the 50Ggct (glucose challenge test) for all the pregnant women attending DH ( Dhulikhel hospital) obstetric OPD, to determine the incidence of GDM in pregnant women and to observe the maternal and fetal outcome among those having an elevated GCT level and gestational diabetes.
METHODS
It was a prospective, analytical study carried out in all the pregnant women attending Dhulikhel hospital obstetrics out patient department between June 2009 to August 2010 after the IRC approval. There were total 1598 pregnant women who were booked as our antenatal cases having no previous history of diabetes mellitus.
These patients underwent the 50g GCT between 24 and 28 weeks of gestation or at booking( if they come after 28 weeks of gestation.) A 50g glucose drink was administered after the antenatal consultation and 60 minutes later venous blood was drawn for plasma glucose estimation. The glucose oxidase method was performed to estimate the plasma glucose level. A plasma glucose level of 140mg/dl or higher was considered a positive test and these women were considered for 100g OGTT. Using the Carpenter Coustan criteria, a diagnosis of GDM was made if the plasma glucose level: fasting, 95mg/dl, in 1hour=180mg/dl;in 2h=155mg/dl; and in 3hour= 140mg/ dl. (Proceedings of the fourth International WorkshopConference on Gestational Diabetes Mellitus). All patients who had GDM were referred to a dietician and jointly managed by an internist and an obstetrician. They were put on a 1800 kilocalorie diet and started on insulin when indicated. For those women whose sugar levels were well controlled on diet, pregnancy was allowed to progress for spontaneous labour, while for those women who required insulin therapy, pregnancy was terminated at 39 weeks of gestation. After delivery, all infants of diabetic mothers were assessed for congenital malformations, hypoglycaemia and other electrolyte and respiratory disorders. The outcome of the pregnancies was assessed by the gestation and mode of delivery and neonatal outcomes in terms of birth weights, apgar scores, congenital abnormalities, hyperbilirubinaemia, hypoglycaemia or respiratory distress syndrome. The results were analyzed by Microsoft Excel 2010 software using simple manual analysis of frequency and percentage.
RESULTS
A total of 1598 pregnant women were screened antenatally with the 50g GCT. Of these, 198(12.3%) women were found to have a 50g GCT value of greater or equal to 140mg/dl. They underwent formal OGTT and 12(0.75%) women were found to have GDM. 
Original Article
Out of 1510 pregnant women without risk factors 160 (10.5%) had raised GCT and out of 160 raised GCT 8(5%) had abnormal OGTT and 152 (95%) had normal OGTT. Likewise, out of 88 pregnant women with risk factors 38 (43.1%) had raised GCT and out of 38 raised GCT, four(10.5%) had abnormal OGTT and 34(89.5%) had normal OGTT.
The maternal outcome with GCT≥140mg/dl showed that there was no morbidity in 186(75.5%) women whereas pre-eclampsia in seven(13.6%) and abruption placentae was in five(9.9%) out of 198 women.Similarly, the maternal outcome with abnormal OGTT showed that there was no morbidity in seven(58.3%), pre-eclampsia in three(25%) and abruption placenta in two(16.6%) out of 12 women. The perinatal outcome with abnormal OGTT showed that there was macrosomia in six(50%) and premature birth in four(33.3%) out of 12 pregnant women. as shown in table  6 .
DISCUSSION
The glucose challenge test (GCT) performed in all the pregnant women helps to screen out the women with GDM. 5 Since, the GDM is notorious for causing adverse effects in pregnancy and also fetal outcome, so there is clear benefit by screening of GDM as it helps in early treatment. 3 Since the 50g Glucose can easily be available for the GCT purpose and also can be performed in Out patient basis, so it is easy, work friendly, cheap and convenient for screening purpose similar to study performed by Wong L and Tang ASA. 8 Apart from that, the pregnant women not required to come with fasting and also they appreciate the test after explaining the importance. Till now no women complained about the adverse effects of test. So, it is feasible to perform 50g GCT in all pregnant women.
Of the women who underwent the 50g GCT, 198(12.39%) women were found to have an elevated level greater or equal to 140mg/dl and 12(0.75%) women were found to have GDM. So, the incidence of GDM was 0.75% in pregnant women attending Dhulikhel Hospital. and the diagnostic yield was 6.06%. The incidence in our study is lower than that of the study performed by Wong L and Tang ASA which reported the incidence of 8.2% and diagnostic yield of 22.6%. 8 This could be because they use the cut off point of 7.1mmol/l. Like wise study performed by the Yang HX et al showed the incidence of GDM 2.7% which was somehow comparable to our results. 9 Similarly study performed by King H and Ray R et al showed the incidence comparable to our results. 2, 10 The study performed by Wong L and Tang ASA 8 showed that every one in five elevated GCT found to have GDM which was similar to our results as in our case every one in six elevated GCT found to have GDM. In 1973, O'Sullivan et al proposed that a single sample of glucose tolerance performed without dietary preparation could provide an acceptable screening compromise. 12 Hence, developed the concept about the 50g GCT. So study performed in 19,798 women, O'Sullivan reported a sensitivity of 79% and specificity of 87% using a threshold value of 130 mg/ dl whole blood (or 7.9 mmol/l plasma). Based on his study, OGTT done for positive history or obstetrical risk factors yielded poor results with a sensitivity rate of 63% and specificity rate of 56%.In the 1980s those cut-off points were adapted to modern methods for measuring glucose and applied to the modern definition of gestational diabetesglucose intolerance with onset or first recognition during pregnancy. 12 Cousins, favored a cut-off of 130 mg/dl (7.2 mmol/l) while Carpenter, suggested the threshold value be set at 135 mg/ dl (7.5 mmol/l). 7, 13 When the threshold was set at 140mg/ dl, we discovered that 12.39% of the population would need to be further tested with the OGTT and the diagnostic yield was 6. 06%. Since we do have poor patients came to our Out patient service so, for economic reasons, we recommend the threshold of 140mg/dl. At this threshold value, only one out of six of the screened population needs to undergo the OGTT.
We observed the epidemiological data to see any epidemiological risk factors associated with a raised GCT or OGTT result. Study performed by Ray R et al showed that older age that is 30 years and above, Chinese ethnic group, maternal obesity (body mass index > or = 25) and history of > or = 4 pregnancies were associated with raised GCT levels. 10 Our results also showed that 66 (33.3%) Tamang women and 49(24.7%) newars that is mongol groups had high GCT. Out of 12 abnormal OGTT, eight(66.6%) Tamang women and two(16.7%) Newar women had abnormal OGTT. Also the patient with BMI>26 had raised GCT and abnormal OGTT which is similar to study performed by Ray R et al but differ in presentation of age group as in our case the raised GCT and abnormal OGTT was in age group >20years. 10 It may be because in our study population women become pregnant in their younger age. Similarly study performed by Wong L and Tand ASA showed no statistical significant between the raised GCT with respect to age, race and body mass index, like that of study performed by Bhat RA et al. 8, 14 One hndred and sixty(10.5%) out of 1510 pregnant women without risk factors had raised GCT, and out of 160, eight(5%) had abnormal OGTT. Among pregnant lady with risk factor, 38(43.1%) out of 88 had raised GCT and four(10.5%) out of 38 had abnormal OGTT, which is comparable to study performed by Griffin et al. 15 Similarly in perinatal outcome, pregnant women with elevated GCT and abnormal OGTT showed macrosomia in 4.04% and 50%, premature birth in 14.6% and 33.3% respectively. Neonatal jaundice and congenital heart disease in 8.3% was seen only in abnormal OGTT. Our results also similar to the study performed by different authors. 17, 19, 20, 21 
CONCLUSIONS
The 50g GCT when performed on all pregnant women is feasible and also helps to find out GDM. It is easy, work friendly, cheap and convenient for screening purpose It was well tolerated by all the patients. We recommend that the threshold value be set at 140mg/dl because only one-fifth of the population would need to undergo the OGTT and the diagnostic yield was 6.06%. Because of preventable adverse outcome of both maternal and fetus, it is worthwhile to perform early detection of GDM by screening.
